# Doxepin

NDC: 10135-764
Generic name: Doxepin
Labeler / Manufacturer: Marlex Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20231001

FDA application: ANDA202337

## Active ingredients

- DOXEPIN HYDROCHLORIDE: 6 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10135-764"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10135-764
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=06e79a65-1455-804e-e063-6394a90a2f3d